Interactive analyses, visualizations, and deep dives into the life sciences landscape generated using Gosset AI Agent.
Strategic market and pipeline analysis covering dual agonists, oral GLP-1s, and emerging therapeutics reshaping the $57.5B global market.
Comprehensive analysis of the $9.2B IL-15 therapeutics market, covering approved drugs, pipeline programs, and strategic opportunities in cancer immunotherapy.
An in-depth analysis of how emerging players and late entrants are capturing significant market share in the $45B PD-1/PD-L1 inhibitor market.
Analysis of China's $3.7B CLDN18.2 therapeutics market, covering CAR-T, ADCs, bispecifics, and the competitive landscape of 70+ drugs in development.
Interactive map visualization of biotechnology companies across China, showing geographic distribution, market caps, and therapeutic focus areas.